Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0002015796-25-000003
Filing Date
2025-11-19
Accepted
2025-11-19 19:02:15
Documents
1
Period of Report
2025-11-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1763596932.html 4  
1 FORM 4 wk-form4_1763596932.xml 4 9736
  Complete submission text file 0002015796-25-000003.txt   11422
Mailing Address 201 LOMAS SANTA FE DRIVE, SUITE 300 SOLANA BEACH CA 92075
Business Address 201 LOMAS SANTA FE DRIVE, SUITE 300 SOLANA BEACH CA 92075 858-925-7000
LENZ Therapeutics, Inc. (Issuer) CIK: 0001815776 (see all company filings)

EIN.: 844867570 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O LENZ THERAPEUTICS, INC. 445 MARINE VIEW AVENUE, SUITE 320 DEL MAR CA 92014
Business Address
Olsson Shawn (Reporting) CIK: 0002015796 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40532 | Film No.: 251500604